Usanarat Anurathapan

Title: Usanarat Anurathapan: Innovator in Cancer Immunotherapy

Introduction

Usanarat Anurathapan is a notable inventor based in Houston, Texas, recognized for his contributions to the field of cancer immunotherapy. He holds two patents that focus on enhancing the efficacy of immune cells in targeting tumors. His work is pivotal in advancing therapeutic strategies for cancer treatment.

Latest Patents

Anurathapan's latest patents include a significant invention related to histone deacetylase (HDAC) inhibitors. This invention details methods and compositions that up-regulate CAR expression and targeted antigen intensity, thereby increasing antitumor efficacy. The embodiments of this invention employ techniques to enhance the potency of immune cells that express therapeutic proteins. In particular, the methods involve modulating the expression of a CAR transgene in immune cells, such as T cells. Specific embodiments utilize exposure to agents that upregulate the expression of therapeutic proteins, including mitogens, histone deacetylase inhibitors, and DNA methyltransferase inhibitors.

Career Highlights

Anurathapan is affiliated with Baylor College of Medicine, where he conducts research and develops innovative solutions in cancer treatment. His work is characterized by a commitment to improving patient outcomes through advanced immunotherapeutic approaches.

Collaborations

He collaborates with esteemed colleagues, including Juan Fernando Vera Valdes and Malcolm K Brenner, who contribute to the research and development of his innovative projects.

Conclusion

Usanarat Anurathapan's contributions to cancer immunotherapy through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in cancer treatment strategies.